Vilya

United States
Seattle, Washington, United States

Company profile

Vilya company profile

Vilya is a biotechnology company developing a novel class of drugs that precisely target the biology of disease. The company aims to create new medicines to leverage computing to make high throughput screening obsolete and cure diseases.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2022-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$71M
Last funding
Series A / $21M / 2024-06-04
Last equity funding
Series A / $21M
Investors
6
Lead investors
1
Founders
1
Articles
21

Founders and investors

Founders

Sabah Oney

Lead investors

ARCH Venture Partners

Investors

ARCH Venture PartnersLifeforce CapitalMadronaMenlo VenturesNVentures